HomeIOBT • NASDAQ
IO Biotech Inc
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.94M | -4.40% |
Net income | -31.33M | -19.67% |
Net profit margin | — | — |
Earnings per share | -0.46 | -21.72% |
EBITDA | -26.88M | 4.43% |
Effective tax rate | -1.44% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.03M | -58.08% |
Total assets | 67.70M | -55.08% |
Total liabilities | 20.68M | 17.82% |
Total equity | 47.02M | — |
Shares outstanding | 65.88M | — |
Price to book | 1.28 | — |
Return on assets | -85.46% | — |
Return on capital | -109.07% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -31.33M | -19.67% |
Cash from operations | -19.63M | 13.91% |
Cash from investing | -11.00K | 90.18% |
Cash from financing | — | — |
Net change in cash | -20.15M | 9.66% |
Free cash flow | -10.45M | 28.29% |
Previous close
$0.91
Year range
$0.66 - $1.79
Market cap
60.21M USD
Avg Volume
201.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
80
